The Legal Intelligencer | News
By Max Mitchell | November 26, 2018
A jury from the U.S. District Court for the Eastern District of Pennsylvania on Monday awarded $1.16 million in compensatory damages and $5 million in punitive damages to a plaintiff who said his Israeli manager discriminated against him on the basis of age and American nationality.
By Charles Toutant | November 14, 2018
Certification was denied because figuring out which consumers were sold the contaminated pills would require conducting a minitrial for each plaintiff.
By Michael Booth | November 13, 2018
The state of New Jersey has filed a lawsuit against Janssen Pharmaceuticals claiming the company used deceptive practices in the sale of two powerful opioids, Nucynta and Nucynta ER. The company is denying those claims.
Delaware Business Court Insider | News
By Tom McParland | November 13, 2018
A federal judge in Delaware gave final approval Tuesday to a $9 million class-action settlement in Hartig Drug Co.'s antitrust suit against Allergan, after an appeals court in 2016 revived claims that Allergan had tried to suppress generic versions of its eye-care products.
By Sue Reisinger | November 12, 2018
David Stark, executive vice president and chief legal officer of financially strapped Teva Pharmaceutical Industries, based in Teva's U.S. headquarters in Parsippany, New Jersey, had to cut his legal staff by 40 percent since 2017 as part of cost-cutting at the Israel-based company. "It was super difficult and hard on morale.” He also plans reductions in outside legal spending.
New Jersey Law Journal | Analysis
By Adam M. Slater | November 9, 2018
Taken together, the decisions represent an established philosophy that will shape the outcomes of significant litigation in New Jersey for years to come.
By Amanda Bronstad | November 5, 2018
“A boundless expansion of tort doctrine.” “Puts the cart before the horse.” “Kicks the can down the road.” That's how opioid companies have described an Oct. 5 report and recommendation that refused to dismiss a bellwether case against them.
By Amanda Bronstad | October 25, 2018
Michael London, co-lead plaintiffs' counsel in the multidistrict litigation in New Jersey, asked the court to set up a qualified settlement fund of a “confidential settlement amount” to resolve his inventory of cases.
New Jersey Law Journal | Analysis
By Brad A. Molotsky | October 17, 2018
Negotiating and drafting leases for businesses that grow or dispense medical marijuana is not "business as usual."
By Michael Booth | October 12, 2018
The U.S. Court of Appeals for the Third Circuit affirmed an order lodged against the doctor, Afoluso Adesanya, and her husband, Adenakan Adesanya, by U.S. District Judge Susan Wigenton in their suit against Novartis Pharmaceuticals Corp.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
d Arcambal Ousley & Cuyler Burk, LLP, a well-established women-owned litigation firm, has an opening in our Parsippany, NJ office. We of...
Our client, a litigation services boutique, is seeking to add a senior litigation associate to support their rapidly growing practice. A Big...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...